{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:34Z","timestamp":1792089994970,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11269-7","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:13:36Z","timestamp":1790550816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Weight loss despite nutritional support predicts poor outcomes after postoperative chemoradiotherapy for high-risk head and neck cancer"],"prefix":"10.1007","volume":"34","author":[{"given":"Yuka","family":"Inamochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Enokida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erisa","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Saino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"11269_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"11269_CR2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394:1915\u20131928. https:\/\/doi.org\/10.1016\/S0140-6736(19)32591-7","journal-title":"Lancet"},{"key":"11269_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJMoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri R, Haddad RI, Tao Y et al (2025) Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med 393:37\u201350. https:\/\/doi.org\/10.1056\/NEJMoa2415434","journal-title":"N Engl J Med"},{"key":"11269_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0140-6736(25)01850-1","volume":"407","author":"J Bourhis","year":"2026","unstructured":"Bourhis J, Aup\u00e9rin A, Borel C et al (2026) Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018\u201301 NIVOPOST-OP): a randomised, open-label, phase 3 trial. Lancet 407:363\u2013374. https:\/\/doi.org\/10.1016\/S0140-6736(25)01850-1","journal-title":"Lancet"},{"key":"11269_CR5","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1200\/JCO.23.02625","volume":"42","author":"M Dzienis","year":"2024","unstructured":"Dzienis M, Cundom J, Fuentes CS et al (2024) Pembrolizumab plus carboplatin and paclitaxel as first-line therapy for recurrent\/metastatic head and neck squamous cell carcinoma (KEYNOTE-B10): a single-arm Phase IV trial. J Clin Oncol 42:2989\u20132999. https:\/\/doi.org\/10.1200\/JCO.23.02625","journal-title":"J Clin Oncol"},{"key":"11269_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-50081-5","volume":"16","author":"J Yoshida","year":"2026","unstructured":"Yoshida J, Fukuda N, Ito T et al (2026) Real-world platinum selection in immune checkpoint inhibitor-based therapy for recurrent or metastatic head and neck cancer: an exploratory multi-institutional retrospective study. Sci Rep 16:18876. https:\/\/doi.org\/10.1038\/s41598-026-50081-5","journal-title":"Sci Rep"},{"key":"11269_CR7","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S1470-2045(25)00087-7","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen X, Beilman B, Gibbs HD et al (2025) Nutrition in head and neck cancer care: a roadmap and call for research. Lancet Oncol 26:e300\u2013e310. https:\/\/doi.org\/10.1016\/S1470-2045(25)00087-7","journal-title":"Lancet Oncol"},{"key":"11269_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-51384-3","volume":"16","author":"M \u00d6zt\u00fcrk \u0130yilikci","year":"2026","unstructured":"\u00d6zt\u00fcrk \u0130yilikci M, Hopanc\u0131 B\u0131\u00e7akl\u0131 D, \u00d6zkaya Akag\u00fcnd\u00fcz \u00d6, Balc\u0131 Topuz B, Esassolak M (2026) Dose-dependent effects of radiotherapy on body composition, nutritional status, and clinical symptoms in head and neck cancer. Sci Rep 16:24968. https:\/\/doi.org\/10.1038\/s41598-026-51384-3","journal-title":"Sci Rep"},{"key":"11269_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00520-025-10051-5","volume":"33","author":"H-Y Lin","year":"2025","unstructured":"Lin H-Y, Feng H-C, Wang Y-J (2025) Trajectory of weight loss and nutritional decline in head and neck cancer patients undergoing concurrent chemoradiotherapy: a longitudinal observational study. Support Care Cancer 33:991. https:\/\/doi.org\/10.1007\/s00520-025-10051-5","journal-title":"Support Care Cancer"},{"key":"11269_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2025.102960","volume":"78","author":"J Zhang","year":"2025","unstructured":"Zhang J, Fan Y, Pu M, Zhang J (2025) Prevalence and risk factors for critical weight loss among patients with head and neck cancer undergoing radiotherapy: a systematic review and meta-analysis. Eur J Oncol Nurs 78:102960. https:\/\/doi.org\/10.1016\/j.ejon.2025.102960","journal-title":"Eur J Oncol Nurs"},{"key":"11269_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jama.2026.1114","volume":"335","author":"S Shen","year":"2026","unstructured":"Shen S, Brown KA, Green AK, Iyengar NM (2026) Obesity and cancer: a translational science review. JAMA 335:1341\u20131350. https:\/\/doi.org\/10.1001\/jama.2026.1114","journal-title":"JAMA"},{"key":"11269_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69476-3","volume":"14","author":"J Yoshida","year":"2024","unstructured":"Yoshida J, Hayashi T, Munetsuna E et al (2024) Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer. Sci Rep 14:18494. https:\/\/doi.org\/10.1038\/s41598-024-69476-3","journal-title":"Sci Rep"},{"key":"11269_CR13","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1007\/s00018-020-03752-z","volume":"78","author":"A Kulkarni","year":"2021","unstructured":"Kulkarni A, Bowers LW (2021) The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis. Cell Mol Life Sci 78:3423\u20133442. https:\/\/doi.org\/10.1007\/s00018-020-03752-z","journal-title":"Cell Mol Life Sci"},{"key":"11269_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105375","volume":"224","author":"T Kono","year":"2026","unstructured":"Kono T, Kasahara K, Tomisato S, Ozawa H (2026) Prognostic impact of CT-defined sarcopenia and prognostic nutritional index in immune checkpoint inhibitor-treated head and neck squamous cell carcinoma: a systematic review and meta-analysis. Crit Rev Oncol Hematol 224:105375. https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105375","journal-title":"Crit Rev Oncol Hematol"},{"key":"11269_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","volume":"27","author":"J Bernier","year":"2005","unstructured":"Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843\u2013850. https:\/\/doi.org\/10.1002\/hed.20279","journal-title":"Head Neck"},{"key":"11269_CR16","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/JCO.21.01293","volume":"40","author":"N Kiyota","year":"2022","unstructured":"Kiyota N, Tahara M, Mizusawa J et al (2022) Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): a multicenter, noninferiority, phase II\/III randomized controlled trial. J Clin Oncol 40:1980\u20131990. https:\/\/doi.org\/10.1200\/JCO.21.01293","journal-title":"J Clin Oncol"},{"key":"11269_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/bjc.2013.458","volume":"109","author":"JAE Langius","year":"2013","unstructured":"Langius JAE, Bakker S, Rietveld DHF et al (2013) Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer 109:1093\u20131099. https:\/\/doi.org\/10.1038\/bjc.2013.458","journal-title":"Br J Cancer"},{"key":"11269_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/hed.27898","volume":"47","author":"AJ Bastien","year":"2025","unstructured":"Bastien AJ, Amin L, Vasquez M et al (2025) Baseline weight recovery and mortality risk in head and neck cancer. Head Neck 47:139\u2013149. https:\/\/doi.org\/10.1002\/hed.27898","journal-title":"Head Neck"},{"key":"11269_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/hed.20737","volume":"30","author":"G Capuano","year":"2008","unstructured":"Capuano G, Grosso A, Gentile PC et al (2008) Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 30:503\u2013508. https:\/\/doi.org\/10.1002\/hed.20737","journal-title":"Head Neck"},{"key":"11269_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-014-0319-y","volume":"10","author":"P Ghadjar","year":"2015","unstructured":"Ghadjar P, Hayoz S, Zimmermann F et al (2015) Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10\/94). Radiat Oncol 10:21. https:\/\/doi.org\/10.1186\/s13014-014-0319-y","journal-title":"Radiat Oncol"},{"key":"11269_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96598-9","volume":"11","author":"C-W Luan","year":"2021","unstructured":"Luan C-W, Tsai Y-T, Yang H-Y, Chen K-Y, Chen P-H, Chou H-H (2021) Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis. Sci Rep 11:17117. https:\/\/doi.org\/10.1038\/s41598-021-96598-9","journal-title":"Sci Rep"},{"key":"11269_CR22","doi-asserted-by":"publisher","unstructured":"do Lima ENS, Ferreira IB, de Paiva Maia YC, Pena GG (2026) Associations of nutritional risk, pre-treatment malnutrition, and cachexia with mortality, local recurrence, and metastasis in head and neck cancer: a five-year prospective cohort study. BMC Cancer 26:232. https:\/\/doi.org\/10.1186\/s12885-025-15373-5","DOI":"10.1186\/s12885-025-15373-5"},{"key":"11269_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373\u20131379. https:\/\/doi.org\/10.1016\/S0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"key":"11269_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hed.26548","volume":"43","author":"DR Dickstein","year":"2021","unstructured":"Dickstein DR, Egerman M, Monrose E et al (2021) Treatment tolerability and outcomes in elderly patients with head and neck cancer. Head Neck 43:858\u2013873. https:\/\/doi.org\/10.1002\/hed.26548","journal-title":"Head Neck"},{"key":"11269_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hed.27249","volume":"45","author":"CL Blake","year":"2023","unstructured":"Blake CL, Brown TE, Pelecanos A et al (2023) Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiving definitive or adjuvant helical intensity-modulated radiotherapy with concurrent chemotherapy. Head Neck 45:417\u2013430. https:\/\/doi.org\/10.1002\/hed.27249","journal-title":"Head Neck"},{"key":"11269_CR26","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1007\/s00405-023-07954-6","volume":"280","author":"E Atasever Akkas","year":"2023","unstructured":"Atasever Akkas E, Erdis E, Yucel B (2023) Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer. Eur Arch Otorhinolaryngol 280:3821\u20133830. https:\/\/doi.org\/10.1007\/s00405-023-07954-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"11269_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/00016489.2023.2288910","volume":"143","author":"N Miyamoto","year":"2023","unstructured":"Miyamoto N, Takenaka Y, Sudo T et al (2023) Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. Acta Otolaryngol 143:925\u2013930. https:\/\/doi.org\/10.1080\/00016489.2023.2288910","journal-title":"Acta Otolaryngol"},{"key":"11269_CR28","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.21873\/anticanres.17234","volume":"44","author":"S Matsumura","year":"2024","unstructured":"Matsumura S, Kaira K, Kuba K et al (2024) Potential of nutritional markers as predictors after immunotherapy in advanced head and neck squamous cell carcinoma. Anticancer Res 44:4049\u20134056. https:\/\/doi.org\/10.21873\/anticanres.17234","journal-title":"Anticancer Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11269-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:37Z","timestamp":1792086517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11269-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11269"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11269-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-10079515\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the Japanese Foundation for Cancer Research (Approval No. 2023-GB-076).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study information was disclosed on the institutional website, and patients were provided with the opportunity to opt out.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1025"}}